Corcept Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Alaunos Therapeutics USD 4K 822K 2024-10
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Ardelyx USD 77.83M 7.33M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
J&J USD 50.32B 1.44B 2024-12
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Pacira USD 309.92M 3.52M 2024-12
Pfizer USD 43B 216M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12



Corcept Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.